Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era

Interstitial lung disease is recognized as a group of diseases with a different etiopathogenesis characterized by chronic lung inflammation with the accumulation of inflammatory cells, lymphocytes and macrophages, and the consequent release of proinflammatory cytokines. Various degrees of pulmonary...

Full description

Bibliographic Details
Main Authors: Sara Cherri, Silvia Noventa, Martina Fanelli, Giulio Calandra, Tiziana Prochilo, Claudio Bnà, Giordano Savelli, Alberto Zaniboni
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
lung toxicity
interstitial lung disease
pneumonitis
cancer treatment
target therapy
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/13/5/1052

Internet

https://www.mdpi.com/2072-6694/13/5/1052

Similar Items